Written by Aisha Saleem, Pharmacist & Health Writer at PharmaHealths.com
Last Updated: July 2026
One of the most common points of confusion I encounter is when patients assume that because their immune system is involved in their skin condition, it must be either autoimmune or allergic, as though these two categories are interchangeable. In reality, they are not interchangeable and represent two fundamentally different immune pathways. Autoimmune and allergic diseases both involve a dysregulated immune response, but they differ fundamentally in what the immune system is reacting to, how that reaction is mediated, which immune cells and molecules are involved, and what the treatment implications are. For anyone managing a chronic skin condition like psoriasis or eczema, understanding this distinction helps clarify why your diagnosis matters and why the right treatment depends on which immune mechanism is actually driving your disease.
What Is an Autoimmune Disease and How Does the Immune Mechanism Work?
An autoimmune disease is a condition in which the immune system mistakenly mounts a sustained response against the body’s own healthy tissues, treating self-antigens as though they were foreign threats. Self-antigens are the body’s own proteins and structures that the immune system should recognize as belonging to itself and leave undisturbed. When this self-tolerance breaks down, immune cells including T lymphocytes and B lymphocytes become activated against these self-antigens, producing inflammation and tissue damage that persists as long as the immune attack continues.
According to the National Institute of Allergy and Infectious Diseases, more than eighty recognized autoimmune conditions exist, including rheumatoid arthritis, type 1 diabetes, multiple sclerosis, psoriasis, and systemic lupus erythematosus. The defining feature of all autoimmune diseases is that the immune system is reacting against self, not against an external trigger, which means the disease process is internally driven and cannot be resolved simply by avoiding environmental exposures.
In psoriasis, the autoimmune mechanism involves T cells, particularly Th17 cells, being activated against skin-associated antigens and driving the production of IL-17 and IL-23, the cytokines that trigger rapid skin cell turnover and sustain inflammation. Research published in the Journal of Investigative Dermatology has established that this T cell mediated response to self-antigens in the skin is the central pathogenic event in psoriasis, which is why biologic drugs that block T cell signaling pathways, specifically the IL-17 and IL-23 cytokines they produce, are so effective.
What Is an Allergic Disease and How Does the Immune Mechanism Differ?
An allergic disease occurs when the immune system mounts an exaggerated response to an external substance that is ordinarily harmless, called an allergen. Unlike autoimmune disease where the target is self, in allergic disease the immune system is reacting to something outside the body, such as pollen, dust mites, pet dander, food proteins, or contact allergens like nickel or fragrances.
The central mechanism in classical allergy involves immunoglobulin E, commonly written as IgE, an antibody class produced by B cells in response to allergen exposure. When an allergen is encountered, allergen-specific IgE antibodies are produced and bind to receptors on the surface of mast cells and basophils throughout the body. On re-exposure to the same allergen, it binds to the IgE already attached to these cells, triggering rapid degranulation and release of histamine, leukotrienes, and other inflammatory mediators that produce the typical allergic response: itching, redness, swelling, and in severe cases anaphylaxis.
According to the American Academy of Allergy, Asthma and Immunology, IgE-mediated allergy requires prior sensitization, meaning the immune system must have been exposed to the allergen at least once before a clinical reaction occurs on subsequent exposures. This is why people do not have allergic reactions the very first time they encounter an allergen they will eventually become sensitive to.
Where Does Eczema Sit: Autoimmune or Allergic?
Atopic dermatitis sits at the intersection of both categories, which is part of why it generates so much confusion. It is not a classic autoimmune disease in which immune cells attack self-tissue directly, but it is also not a simple IgE-mediated allergy. Research published in the Journal of Allergy and Clinical Immunology has characterized atopic dermatitis as a condition involving a combination of genetic skin barrier dysfunction, elevated IgE and allergen sensitization typical of allergic disease, and a chronically overactive Th2 immune response that has elements of both allergic and immune-mediated dysfunction.
In severe, longstanding atopic dermatitis, there is even evidence of IgE autoantibodies, antibodies targeting the body’s own skin proteins rather than external allergens, suggesting that chronic disease progression may introduce autoimmune-like features over time. This complexity means atopic dermatitis is most accurately described as an immune-mediated inflammatory disease with both allergic and autoimmune features, rather than fitting neatly into either category.
What Is the Role of Immune Tolerance Failure in Both Disease Types?
Both autoimmune and allergic diseases share a fundamental underlying problem: a failure of immune tolerance. Immune tolerance is the mechanism by which the immune system learns to ignore things it should not attack, including the body’s own tissues in autoimmunity and harmless environmental substances in allergy. Research published in Nature Reviews Immunology has established that regulatory T cells, a specialized immune cell subset called Tregs, are central to maintaining this tolerance in both autoimmune and allergic conditions.
In autoimmune disease, Treg dysfunction allows self-reactive T cells to become activated against body tissues unchecked. In allergic disease, Treg failure allows Th2 cells to mount exaggerated responses to harmless environmental allergens that should be ignored. This shared mechanism of tolerance failure is one reason patients with one autoimmune condition have a higher statistical risk of developing others, and why individuals with allergic conditions like eczema have elevated rates of asthma and hay fever, all driven by the same underlying failure of immune regulation.
Can You Have Both an Autoimmune Disease and Allergies?
Yes, and this is more common than people expect. Research published in the Annals of the Rheumatic Diseases examining genetic overlap between autoimmune and allergic diseases found shared genetic loci associated with immune regulation across both disease categories, which helps explain why autoimmune and allergic conditions frequently co-occur in the same individual. Patients with psoriasis, for example, have a higher-than-average rate of atopic conditions including eczema and asthma, and patients with autoimmune thyroid disease have elevated rates of allergic conditions including chronic urticaria.
According to the American Academy of Allergy, Asthma and Immunology, chronic urticaria itself sits across both categories: some cases are IgE-mediated allergic reactions to identifiable triggers, while others have an autoimmune basis in which autoantibodies directly activate mast cells without any external allergen being involved. Correctly identifying which mechanism is driving chronic urticaria changes the treatment approach significantly.
How Does Treatment Differ Between Autoimmune and Allergic Disease?
The distinction between autoimmune and allergic immune mechanisms directly determines which treatments are effective. In allergic disease, antihistamines block the downstream effects of histamine release, while allergen immunotherapy aims to re-educate the immune system to tolerate the allergen over time. Biologic treatments targeting IgE itself, such as omalizumab for severe allergic asthma and chronic urticaria, are highly effective in IgE-mediated conditions.
In autoimmune disease, treatment aims at suppressing the aberrant self-directed immune response, either broadly with immunosuppressants like methotrexate or azathioprine, or specifically with biologic drugs that block the cytokines driving the self-attack. For psoriasis, IL-17 and IL-23 inhibitors block the T cell-derived cytokines responsible for the autoimmune inflammatory cascade. For atopic dermatitis, dupilumab targets the IL-4 and IL-13 pathway that sits at the junction between allergic and autoimmune mechanisms in this condition.
Research published in the British Journal of Dermatology has highlighted that matching the treatment to the correct immune mechanism is what determines long-term efficacy, which is why a drug highly effective in psoriasis may be ineffective in eczema and vice versa, even though both conditions look similar from the outside.
The Bottom Line
Autoimmune and allergic diseases both involve the immune system behaving abnormally, but they differ fundamentally in what the immune system is reacting to, how the reaction is mediated, and which treatments are effective. Autoimmune diseases target the body’s own tissues via T cell and autoantibody mechanisms. Allergic diseases target external allergens via IgE and mast cell mechanisms. Some conditions, particularly atopic dermatitis and chronic urticaria, bridge both categories. Understanding which mechanism is driving your condition is not just academic knowledge: it determines which treatment pathway gives you the best chance of achieving real, sustained control.
FAQs
Q1: What is the difference between an autoimmune disease and an allergic disease?
An autoimmune disease occurs when the immune system attacks the body’s own healthy tissues, driven by self-reactive T cells and autoantibodies targeting self-antigens. An allergic disease occurs when the immune system mounts an exaggerated response to a harmless external substance, mediated by IgE antibodies and mast cell activation. Both involve immune dysregulation but target completely different things and require different treatments.
Q2: Is eczema an autoimmune or allergic disease?
Atopic dermatitis sits between both categories. It involves elevated IgE and allergen sensitization typical of allergic disease, alongside a chronically overactive Th2 immune response with elements of immune-mediated inflammation. In severe chronic cases, IgE autoantibodies targeting the body’s own skin proteins have also been identified. Atopic dermatitis is most accurately described as an immune-mediated inflammatory condition with both allergic and autoimmune features.
Q3: Is psoriasis an autoimmune disease?
Yes, Psoriasis is classified as an autoimmune condition in which T cells, particularly Th17 cells, are activated against skin-associated self-antigens and drive production of IL-17 and IL-23, causing rapid skin cell turnover and chronic plaque inflammation.
Q4: Can you have both an autoimmune disease and allergies?
Yes. Research has shown shared genetic loci associated with immune regulation across both autoimmune and allergic disease categories, which explains why they frequently co-occur.
Q5: What is the role of IgE in allergic disease?
IgE is the antibody class central to classical allergic reactions. When the immune system is sensitized to an allergen, B cells produce allergen-specific IgE antibodies that bind to receptors on mast cells. On re-exposure, this triggers release of histamine and other mediators responsible for symptoms.
Q6: Is chronic urticaria autoimmune or allergic?
Chronic urticaria can be either. Some cases are IgE-mediated reactions to external allergens, while others involve autoantibodies activating mast cells without any allergen trigger.
Q7: Why do autoimmune diseases cause higher allergy risk?
Both conditions share failure of immune tolerance mediated by regulatory T cells. When this control system breaks down, both self-directed and exaggerated external responses can occur.
Q8: Why do autoimmune drugs not always work for allergies?
Autoimmune treatments target T cell-driven inflammation, while allergic diseases are primarily driven by IgE and mast cell activation. Because these are different pathways, treatments are not interchangeable.
Call To Action
If this article helped clarify the difference between autoimmune and allergic immune mechanisms, explore more detailed treatment guides on PharmaHealths.com.
Disclaimer
This article is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor, dermatologist, or pharmacist before making any changes to your treatment.
References
• National Institute of Allergy and Infectious Diseases
• Journal of Investigative Dermatology
• American Academy of Allergy, Asthma and Immunology
• Journal of Allergy and Clinical Immunology
• Nature Reviews Immunology
• Annals of the Rheumatic Diseases
• British Journal of Dermatology
